Dr. Yoshiteru Shimoide, immunologist and director of the Yoshiteru Shimoide Internal Medicine Clinic in Kagoshima, Japan, has developed RO‑8, the world’s first therapeutic agent designed to ...
Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...
The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...
The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Scientists discover aloe vera compound could offer breakthrough Alzheimer's treatment. Beta sitosterol shows promising results in computer simulations.
A study finds that people who stay mentally active through reading, writing, and learning may have a lower risk of ...
After an analysis of health data from over 131,000 people tracked for up to 43 years, researchers found that drinking coffee ...
The neuron’s inner scaffold, once viewed as static support, now looks like a gatekeeper. Research findings are available ...
Some forms of dementia may not be confined to the central nervous system; they may not even begin in the brain.
Morning Overview on MSN
1 in 3 dementia cases tied to a disease that starts outside the brain
Roughly 37% of new dementia cases in older Americans may be linked to diseases that begin outside the brain, according to a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results